Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Nov. 19, 2013, 167 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $93.28 to $173,250,000.00. Highlighted Stocks Traded by Insiders: Group 1 Automotive (GPI) - FREE Research Report DeLongchamps Peter C who is VP, Financial Svcs/Mfr Rel at Group 1 Automotive sold 6,999 shares at $66.00 on Nov. 19, 2013. Following this transaction, the VP, Financial Svcs/Mfr Rel owned 47,895 shares meaning that the stake was reduced by 12.75% with the 6,999 share transaction. The shares most recently traded at $65.98, down $0.02, or 0.03% since the insider transaction. Historical insider transactions for Group 1 Automotive go as follows:
- 12-Week # shares sold: 3,148
- 24-Week # shares sold: 5,540
Vertex Pharmaceuticals (VRTX) - FREE Research Report Connolly Thomas who is SVP, Human Resources at Vertex Pharmaceuticals sold 150 shares at $61.05 on Nov. 19, 2013. Following this transaction, the SVP, Human Resources owned 4,252 shares meaning that the stake was reduced by 3.41% with the 150 share transaction. Pace Megan E who is SVP, Corp. Communications at Vertex Pharmaceuticals sold 93 shares at $60.97 on Nov. 19, 2013. Following this transaction, the SVP, Corp. Communications owned 17,271 shares meaning that the stake was reduced by 0.54% with the 93 share transaction. The shares most recently traded at $64.61, up $3.64, or 5.63% since the insider transaction. Historical insider transactions for Vertex Pharmaceuticals go as follows:
- 4-Week # shares sold: 9,050
- 12-Week # shares sold: 38,067
- 24-Week # shares sold: 60,208
Iconix Brand Group (ICON) - FREE Research Report Friedman Mark A who is Director at Iconix Brand Group sold 9,776 shares at $38.47 on Nov. 19, 2013. Following this transaction, the Director owned 39,925 shares meaning that the stake was reduced by 19.67% with the 9,776 share transaction. The shares most recently traded at $37.62, down $0.85, or 2.26% since the insider transaction. Historical insider transactions for Iconix Brand Group go as follows:
- 24-Week # shares sold: 7,815
Fairchild Semiconductor International (FCS) - FREE Research Report Delva Paul D who is Senior Vice President at Fairchild Semiconductor International sold 17,000 shares at $12.46 on Nov. 19, 2013. Following this transaction, the Senior Vice President owned 57,815 shares meaning that the stake was reduced by 22.72% with the 17,000 share transaction. The shares most recently traded at $12.36, down $0.10, or 0.81% since the insider transaction. Historical insider transactions for Fairchild Semiconductor International go as follows:
- 12-Week # shares bought: 20,000
- 12-Week # shares sold: 36,732
- 24-Week # shares bought: 20,000
- 24-Week # shares sold: 36,732
Imperva (IMPV) - FREE Research Report Shulman Amichai who is Chief Technology Officer at Imperva sold 235 shares at $39.43 on Nov. 19, 2013. Following this transaction, the Chief Technology Officer owned 10,000 shares meaning that the stake was reduced by 2.3% with the 235 share transaction. Kraynak Mark E. who is Senior VP, Worldwide Marketing at Imperva sold 3,190 shares at $37.80 on Nov. 19, 2013. Following this transaction, the Senior VP, Worldwide Marketing owned 15,000 shares meaning that the stake was reduced by 17.54% with the 3,190 share transaction. The shares most recently traded at $38.00, up $0.20, or 0.53% since the insider transaction. Historical insider transactions for Imperva go as follows:
- 24-Week # shares sold: 750